Connecting you to content on EBSCOhost

Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 1

Results: 6

1

Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 1, p. 1, doi. 10.1007/s002620050021

By:

Ichii, Shinji;
Imai, Yasuyuki;
Irimura, Tatsuro

Publication type:

Article

2

B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 1, p. 10, doi. 10.1007/s002620050022

By:

Sojka, Dorothy K.;
La Motte, Ross N.;
Mokyr, Margalit B.

Publication type:

Article

3

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 1, p. 56, doi. 10.1007/s002620050026

By:

Douillard, J. Y.;
Bennouna, J.;
Vavasseur, F.;
Deporte-Fety, R.;
Thomare, P.;
Giacalone, F.;
Meflah, K.

Publication type:

Article

4

Immune gene therapy of experimental mouse brain tumor with adenovirus-mediated gene transfer of murine interleukin-4.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 1, p. 23, doi. 10.1007/s002620050023

By:

Yoshikawa, Koichi;
Kajiwara, Koji;
Ideguchi, Makoto;
Uchida, Tetsuya;
Ito, Haruhide

Publication type:

Article

5

Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 1, p. 46, doi. 10.1007/s002620050025

By:

Nagarkatti, Nisha

Publication type:

Article

6

Immunotherapy with vaccines combining MHC class II/CD80<sup>+</sup> tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γ.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 1, p. 34, doi. 10.1007/s002620050024

By:

Pulaski, Beth A.;
Clements, Virginia K.;
Pipeling, Matthew R.;
Ostrand-Rosenberg, Suzanne

Publication type:

Article